- Home
- MOLN vs MVST Comparison
MOLN vs MVST Comparison
Compare MOLN & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | MVST |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.9M | 987.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOLN | MVST |
|---|---|---|
| Price | $4.00 | $1.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.38 | $6.00 |
| AVG Volume (30 Days) | 3.4K | ★ 5.1M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.85 |
| Revenue Next Year | $318.52 | $36.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.36 | $1.37 |
| 52 Week High | $5.36 | $7.12 |
Technical Indicators
Market Signals| Indicator | MOLN | MVST |
|---|---|---|
| Relative Strength Index (RSI) | 31.45 | 33.15 |
| Support Level | $3.51 | N/A |
| Resistance Level | $4.01 | $2.49 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 10.78 | 6.67 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.